{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:03:32Z","timestamp":1788897812112,"version":"build-2803163510"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01368-2","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:35:10Z","timestamp":1775140510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advancing diagnostic biomarkers in Alzheimer\u2019s disease: interdisciplinary innovations and technological frontiers"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0453-8126","authenticated-orcid":false,"given":"Faheem","family":"Patwekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5043-366X","authenticated-orcid":false,"given":"Mohsina","family":"Patwekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Seong","family":"wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-3573","authenticated-orcid":false,"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-2261","authenticated-orcid":false,"given":"Ryan","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arifullah","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"3","key":"1368_CR1","first-page":"645","volume":"57","author":"FT Hane","year":"2017","unstructured":"Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS. Recent progress in AD research, part 3: diagnosis and treatment. Journal of AD. 2017;57(3):645\u201365.","journal-title":"Journal of AD"},{"key":"1368_CR2","first-page":"2022","volume":"17","author":"SS Pange","year":"2022","unstructured":"Pange SS, Patwekar M, Patwekar F, Alghamdi S, et al. A potential notion on AD: nanotechnology as an alternative solution. J Nanomater. 2022;17:2022.","journal-title":"J Nanomater"},{"issue":"3","key":"1368_CR3","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.24294\/ace.v6i3.2338","volume":"6","author":"M Patwekar","year":"2023","unstructured":"Patwekar M, Patwekar F, Shaikh D, Fatema SR, Aher SJ, Sharma R. Receptor-based approaches and therapeutic targets in AD along with role of AI in drug designing: unraveling pathologies and advancing treatment strategies. Appl Chem Eng. 2023;6(3):2338.","journal-title":"Appl Chem Eng."},{"issue":"2","key":"1368_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/1596-3519.82057","volume":"10","author":"FK Salawu","year":"2011","unstructured":"Salawu FK, Umar JT, Olokoba AB. AD: a review of recent developments. Ann Afr Med. 2011;10(2):73\u20139.","journal-title":"Ann Afr Med."},{"key":"1368_CR5","first-page":"371","volume":"8","author":"AP Porsteinsson","year":"2021","unstructured":"Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of early AD: clinical practice in 2021. J Prev AD. 2021;8:371\u201386.","journal-title":"J Prev AD"},{"issue":"2","key":"1368_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1053-8119(02)00026-5","volume":"18","author":"G A\u00eblChetelat","year":"2003","unstructured":"A\u00eblChetelat G, Baron JC. Early diagnosis of AD: contribution of structural neuroimaging. Neuroimage. 2003;18(2):525\u201341.","journal-title":"Neuroimage"},{"issue":"10","key":"1368_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-008696","volume":"7","author":"L Albarqouni","year":"2022","unstructured":"Albarqouni L, Arab-Zozani M, Abukmail E, et al. Overdiagnosis and overuse of diagnostic and screening tests in low-income and middle-income countries: a scoping review. BMJ Glob Health. 2022;7(10):e008696.","journal-title":"BMJ Glob Health"},{"issue":"1","key":"1368_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/07317115.2011.626516","volume":"35","author":"PA Lichtenberg","year":"2012","unstructured":"Lichtenberg PA. Misdiagnosis of AD: Case studies in capacity assessment. Clin Gerontol. 2012;35(1):42\u201356.","journal-title":"Clin Gerontol"},{"issue":"3","key":"1368_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois B, Hampel H, Feldman HH, et al. Preclinical AD: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292\u2013323.","journal-title":"Alzheimers Dement"},{"key":"1368_CR10","doi-asserted-by":"crossref","unstructured":"Grand J, Feldman HH. Historical concepts of AD and dementia. Feldman HH (Ed): Atlas of AD. Informa Healthcare, London. 2007. pp1\u201326.","DOI":"10.3109\/9781435626133-1"},{"issue":"71","key":"1368_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.artmed.2016.06.003","volume":"1","author":"A Alberdi","year":"2016","unstructured":"Alberdi A, Aztiria A, Basarab A. On the early diagnosis of AD from multi-modal signals: a survey. Artif Intell Med. 2016;1(71):1\u201329.","journal-title":"Artif Intell Med"},{"key":"1368_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/01.ede.0000142147.49297.9d","volume":"1","author":"C Qiu","year":"2004","unstructured":"Qiu C, Fratiglioni L, Karp A, Winblad B, Bellander T. Occupational exposure to electromagnetic fields and risk of AD. Epidemiology. 2004;1:687\u201394.","journal-title":"Epidemiology"},{"issue":"22","key":"1368_CR13","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.2174\/1568026622666220902110115","volume":"22","author":"SA Parvathy Dharshini","year":"2022","unstructured":"Parvathy Dharshini SA, Sneha NP, Yesudhas D, et al. Exploring plausible therapeutic targets for AD using multi-omics approach, machine learning and docking. Curr Top Med Chem. 2022;22(22):1868\u201379.","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"1368_CR14","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/tbed.13598","volume":"67","author":"AR Cameron","year":"2020","unstructured":"Cameron AR, Meyer A, Faverjon C, Mackenzie C. Quantification of the sensitivity of early detection surveillance. Transbound Emerg Dis. 2020;67(6):2532\u201343.","journal-title":"Transbound Emerg Dis"},{"issue":"1","key":"1368_CR15","volume":"12","author":"RF Allegri","year":"2020","unstructured":"Allegri RF, Chrem M\u00e9ndez P, Calandri I, et al. Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine AD Neuroimaging Initiative. Alzheimer\u2019s Dementia Diagn Assess Dis Monit. 2020;12(1):e12026.","journal-title":"Alzheimer's Dementia Diagn Assess Dis Monit"},{"issue":"6","key":"1368_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1373\/clinchem.2013.202937","volume":"59","author":"JH Kang","year":"2013","unstructured":"Kang JH, Korecka M, Toledo JB, Trojanowski JQ, Shaw LM. Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-\u03b21\u201342 and \u03c4 proteins as Alzheimer disease biomarkers. Clin Chem. 2013;59(6):903\u201316.","journal-title":"Clin Chem"},{"issue":"32","key":"1368_CR17","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.neurobiolaging.2011.09.004","volume":"1","author":"R Mayeux","year":"2011","unstructured":"Mayeux R, Schupf N. Blood-based biomarkers for AD: plasma A\u03b240 and A\u03b242, and genetic variants. Neurobiol Aging. 2011;1(32):S10\u20139.","journal-title":"Neurobiol Aging"},{"key":"1368_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11682-013-9262-z","volume":"8","author":"L Shen","year":"2014","unstructured":"Shen L, Thompson PM, Potkin SG, et al. Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imaging Behav. 2014;8:183\u2013207.","journal-title":"Brain Imaging Behav"},{"issue":"44","key":"1368_CR19","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283(44):29615\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"1368_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0014-4886(03)00384-4","volume":"184","author":"C \u017bekanowski","year":"2003","unstructured":"\u017bekanowski C, Styczy\u0144ska M, Pep\u0142o\u0144ska B, et al. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset AD in Poland. Exp Neurol. 2003;184(2):991\u20136.","journal-title":"Exp Neurol"},{"issue":"1","key":"1368_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B, von Arnim CA, Burnie N, Bozeat S, Cummings J. Biomarkers in AD: role in early and differential diagnosis and recognition of atypical variants. Alzheimer\u2019s Res Ther. 2023;15(1):175.","journal-title":"Alzheimer's Res Ther"},{"issue":"12","key":"1368_CR22","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/ejhg.2010.119","volume":"18","author":"S Ashida","year":"2010","unstructured":"Ashida S, Koehly LM, Roberts JS, Chen CA, Hiraki S, Green RC. The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study. Eur J Hum Genet. 2010;18(12):1296\u2013301.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"1368_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fdata.2021.676168","volume":"20","author":"J Howlett","year":"2021","unstructured":"Howlett J, Hill SM, Ritchie CW, Tom BD. Disease modelling of cognitive outcomes and biomarkers in the European Prevention of Alzheimer\u2019s Dementia Longitudinal Cohort. Front Big Data. 2021;20(4):676168.","journal-title":"Front Big Data"},{"issue":"9","key":"1368_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/brainsci9090213","volume":"9","author":"E Chipi","year":"2019","unstructured":"Chipi E, Salvadori N, Farotti L, Parnetti L. Biomarker-based signature of AD in pre-MCI individuals. Brain Sci. 2019;9(9):213.","journal-title":"Brain Sci"},{"key":"1368_CR25","unstructured":"Mondrag\u00f3na JD, S\u00e1nchez-Catas\u00fasb CA, Mauritsa NM. Tau pathology, neurodegeneration, and neuronal injury biomarker co-occurrence in AT (N) characterized Alzheimer\u2019s and non-AD dementias. Anosognosia of memory deficits in dementia: biomarkers, connectivity, and clinical aspects. 26."},{"key":"1368_CR26","doi-asserted-by":"crossref","unstructured":"Xu Q, Zhang W, Zuo C. Molecular imaging and targeted therapy in neurology. nuclear medicine in oncology: molecular imaging and target therapy. 2019. pp 257\u201366.","DOI":"10.1007\/978-981-13-7458-6_17"},{"key":"1368_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1243132","author":"M Mei","year":"2023","unstructured":"Mei M, Liu M, Mei Y, Zhao J, Li Y. Sphingolipid metabolism in brain insulin resistance and neurological diseases. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1243132.","journal-title":"Front Endocrinol"},{"key":"1368_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2026.156421","author":"F Patwekar","year":"2026","unstructured":"Patwekar F, Patwekar M, Lee SW, et al. Antibody-based nanoparticles in Alzheimer\u2019s disease: innovations in diagnosis and therapy. Pathol Res Pract. 2026. https:\/\/doi.org\/10.1016\/j.prp.2026.156421.","journal-title":"Pathol Res Pract"},{"issue":"8","key":"1368_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.biopsych.2014.08.024","volume":"77","author":"J McConathy","year":"2015","unstructured":"McConathy J, Sheline YI. Imaging biomarkers associated with cognitive decline: a review. Biol Psychiat. 2015;77(8):685\u201392.","journal-title":"Biol Psychiat"},{"issue":"1","key":"1368_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/brain\/awz378","volume":"143","author":"TJ Betthauser","year":"2020","unstructured":"Betthauser TJ, Koscik RL, Jonaitis EM, Allison SL, Cody KA, Erickson CM, et al. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age. Brain. 2020;143(1):320\u201335.","journal-title":"Brain"},{"issue":"84","key":"1368_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2019.07.011","volume":"1","author":"K Blom","year":"2019","unstructured":"Blom K, Koek HL, Zwartbol MH, van der Graaf Y, Kesseler L, Biessels GJ, et al. Subjective cognitive decline, brain imaging biomarkers, and cognitive functioning in patients with a history of vascular disease: the SMART-Medea study. Neurobiol Aging. 2019;1(84):33\u201340.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1368_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6(2):67\u201377.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"1368_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00002093-200307000-00010","volume":"17","author":"M Atiya","year":"2003","unstructured":"Atiya M, Hyman BT, Albert MS, Killiany R. Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review. Alzheimer Dis Assoc Disord. 2003;17(3):177\u201395.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"62","key":"1368_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mri.2019.06.019","volume":"1","author":"TA Shaikh","year":"2019","unstructured":"Shaikh TA, Ali R. Automated atrophy assessment for AD diagnosis from brain MRI images. Magn Reson Imaging. 2019;1(62):167\u201373.","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"1368_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1615\/CritRevBiomedEng.2016019544","volume":"44","author":"O Dona","year":"2016","unstructured":"Dona O, Thompson J, Druchok C. Comprehensive review on magnetic resonance imaging in AD. Crit Rev Biomed Eng. 2016;44(7):213\u201325.","journal-title":"Crit Rev Biomed Eng"},{"issue":"7","key":"1368_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrd1130","volume":"2","author":"R Frank","year":"2003","unstructured":"Frank R, Hargreaves R. Clinical biomarkers in drug discovery and development. Nat Rev Drug Discovery. 2003;2(7):566\u201380.","journal-title":"Nat Rev Drug Discovery"},{"key":"1368_CR37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00439-012-1188-9","volume":"131","author":"A Ziegler","year":"2012","unstructured":"Ziegler A, Koch A, Krockenberger K, Gro\u00dfhennig A. Personalized medicine using DNA biomarkers: a review. Hum Genet. 2012;131:1627\u201338.","journal-title":"Hum Genet"},{"issue":"1","key":"1368_CR38","first-page":"9","volume":"76","author":"JK Aronson","year":"2017","unstructured":"Aronson JK, Ferner RE. Biomarkers-a general review. Curr Protoc Pharmacol. 2017;76(1):9\u201323.","journal-title":"Curr Protoc Pharmacol"},{"issue":"72","key":"1368_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101492","volume":"1","author":"L Feng","year":"2021","unstructured":"Feng L, Li J, Zhang R. Current research status of blood biomarkers in AD: Diagnosis and prognosis. Ageing Res Rev. 2021;1(72):101492.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"1368_CR40","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/jcm9061673","volume":"9","author":"M Paraskevaidi","year":"2020","unstructured":"Paraskevaidi M, Allsop D, Karim S, Martin FL, Crean S. Diagnostic biomarkers for AD using non-invasive specimens. J Clin Med. 2020;9(6):1673.","journal-title":"J Clin Med"},{"key":"1368_CR41","unstructured":"Khan T. Biomarkers in AD. Academic Press. 2016."},{"issue":"3","key":"1368_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000090631","volume":"21","author":"\u00c5K Wallin","year":"2006","unstructured":"Wallin \u00c5K, Blennow K, Andreasen N, Minthon L. CSF biomarkers for AD: levels of \u03b2-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival. Dement Geriatr Cogn Disord. 2006;21(3):131\u20138.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"11","key":"1368_CR43","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/brain\/awl269","volume":"129","author":"K Buerger","year":"2006","unstructured":"Buerger K, Ewers M, Pirttil\u00e4 T, et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in AD. Brain. 2006;129(11):3035\u201341.","journal-title":"Brain"},{"issue":"3","key":"1368_CR44","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.mp.4001220","volume":"8","author":"M Riemenschneider","year":"2003","unstructured":"Riemenschneider M, Wagenpfeil S, Vanderstichele H, et al. Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt\u2013Jakob disease from other dementias. Mol Psychiatry. 2003;8(3):343\u20137.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1368_CR45","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114408","volume":"14","author":"A Leuzy","year":"2022","unstructured":"Leuzy A, Mattsson-Carlgren N, Palmqvist S, Janelidze S, Dage JL, Hansson O. Blood-based biomarkers for AD. EMBO Mol Med. 2022;14(1):e14408.","journal-title":"EMBO Mol Med"},{"issue":"319","key":"1368_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jneumeth.2018.10.025","volume":"1","author":"H Zetterberg","year":"2019","unstructured":"Zetterberg H. Blood-based biomarkers for AD- an update. J Neurosci Methods. 2019;1(319):2\u20136.","journal-title":"J Neurosci Methods"},{"issue":"15","key":"1368_CR47","doi-asserted-by":"publisher","first-page":"e1580","DOI":"10.1212\/WNL.0000000000009240","volume":"94","author":"JD Doecke","year":"2020","unstructured":"Doecke JD, P\u00e9rez-Grijalba V, Fandos N, et al. Total A\u03b242\/A\u03b240 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis. Neurology. 2020;94(15):e1580\u201391.","journal-title":"Neurology"},{"issue":"8","key":"1368_CR48","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1368_CR49","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41582-019-0265-2","volume":"15","author":"I Fyfe","year":"2019","unstructured":"Fyfe I. Neurofilament light chain-new potential for prediction and prognosis. Nat Rev Neurol. 2019;15(10):557.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1368_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JPD-202323","volume":"11","author":"Y Compta","year":"2021","unstructured":"Compta Y, Revesz T. Neuropathological and biomarker findings in Parkinson\u2019s disease and AD: from protein aggregates to synaptic dysfunction. J Parkinsons Dis. 2021;11(1):107\u201321.","journal-title":"J Parkinsons Dis"},{"issue":"65","key":"1368_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101208","volume":"1","author":"A John","year":"2021","unstructured":"John A, Reddy PH. Synaptic basis of AD: Focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev. 2021;1(65):101208.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"1368_CR52","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/biomedicines10040850","volume":"10","author":"S Mankhong","year":"2022","unstructured":"Mankhong S, Kim S, Lee S, et al. Development of AD biomarkers: from CSF-to blood-based biomarkers. Biomedicines. 2022;10(4):850.","journal-title":"Biomedicines"},{"issue":"10","key":"1368_CR53","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke JD, Laws SM, Faux NG, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol. 2012;69(10):1318\u201325.","journal-title":"Arch Neurol"},{"issue":"40","key":"1368_CR54","doi-asserted-by":"publisher","first-page":"12468","DOI":"10.1073\/pnas.1511003112","volume":"112","author":"CM Sandiego","year":"2015","unstructured":"Sandiego CM, Gallezot JD, Pittman B, et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci. 2015;112(40):12468\u201373.","journal-title":"Proc Natl Acad Sci"},{"issue":"165","key":"1368_CR55","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/bs.pmbts.2019.04.005","volume":"1","author":"B Janssen","year":"2019","unstructured":"Janssen B, Mach RH. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in AD. Prog Mol Biol Transl Sci. 2019;1(165):371\u201399.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"14","key":"1368_CR56","doi-asserted-by":"publisher","first-page":"1119315","DOI":"10.3389\/fimmu.2023.1119315","volume":"28","author":"M Yi","year":"2023","unstructured":"Yi M, Li J, Jian S, Li B, Huang Z, Shu L, et al. Quantitative and causal analysis for inflammatory genes and the risk of Parkinson\u2019s disease. Front Immunol. 2023;28(14):1119315.","journal-title":"Front Immunol"},{"issue":"2","key":"1368_CR57","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.24294\/ti.v7.i2.2395","volume":"7","author":"M Patwekar","year":"2023","unstructured":"Patwekar M, Patwekar F, Sanaullah S, Shaikh D, Almas U, Sharma R. Harnessing artificial intelligence for enhanced Parkinson\u2019s disease management: Pathways, treatment, and prospects. Trends Immunother. 2023;7(2):2395.","journal-title":"Trends Immunother"},{"issue":"2","key":"1368_CR58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.60084\/mp.v1i2.60","volume":"1","author":"TR Noviandy","year":"2023","unstructured":"Noviandy TR, Maulana A, Idroes GM, et al. Integrating genetic algorithm and LightGBM for QSAR modeling of acetylcholinesterase inhibitors in AD drug discovery. Malacca Pharmaceut. 2023;1(2):48\u201354.","journal-title":"Malacca Pharmaceut"},{"issue":"14","key":"1368_CR59","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","volume":"24","author":"YT Yeung","year":"2018","unstructured":"Yeung YT, Aziz F, Guerrero-Castilla A, Arguelles S. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24(14):1449\u201384.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"1368_CR60","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/biom11070980","volume":"11","author":"KY Kim","year":"2021","unstructured":"Kim KY, Shin KY, Chang KA. Brain-derived exosomal proteins as effective biomarkers for AD: A systematic review and meta-analysis. Biomolecules. 2021;11(7):980.","journal-title":"Biomolecules"},{"issue":"360","key":"1368_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2015.12.005","volume":"15","author":"V Van Giau","year":"2016","unstructured":"Van Giau V, An SS. Emergence of exosomal miRNAs as a diagnostic biomarker for AD. J Neurol Sci. 2016;15(360):141\u201352.","journal-title":"J Neurol Sci"},{"issue":"9","key":"1368_CR62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/ph13090243","volume":"13","author":"I Manna","year":"2020","unstructured":"Manna I, De Benedittis S, Quattrone A, Maisano D, Iaccino E, Quattrone A. Exosomal miRNAs as potential diagnostic biomarkers in AD. Pharmaceuticals. 2020;13(9):243.","journal-title":"Pharmaceuticals"},{"key":"1368_CR63","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s11064-020-03111-1","volume":"45","author":"S Lakshmi","year":"2020","unstructured":"Lakshmi S, Essa MM, Hartman RE, Guillemin GJ, Sivan S, Elumalai P. Exosomes in AD: potential role as pathological mediators, biomarkers and therapeutic targets. Neurochem Res. 2020;45:2553\u20139.","journal-title":"Neurochem Res"},{"issue":"5","key":"1368_CR64","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K. AD Neuroimaging. Initiative Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA neurology. 2017;74(5):557\u201366.","journal-title":"JAMA neurology."},{"key":"1368_CR65","first-page":"1","volume":"1","author":"LJ De Picker","year":"2021","unstructured":"De Picker LJ, Haarman BC. Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker. Eur J Nucl Med Mol Imaging. 2021;1:1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"1368_CR66","first-page":"1422","volume":"6","author":"E Chumakov","year":"2022","unstructured":"Chumakov E, Dorofeikova M, Tsyrenova K, Petrova N. A cross-sectional study on associations between BDNF, CRP, IL-6 and clinical symptoms, cognitive and personal performance in patients with paranoid schizophrenia. Front Psych. 2022;6(13):1422.","journal-title":"Front Psych"},{"issue":"1","key":"1368_CR67","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","volume":"118","author":"PM Ridker","year":"2016","unstructured":"Ridker PM. From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Circ Res. 2016;118(1):145\u201356.","journal-title":"Circ Res"},{"issue":"4","key":"1368_CR68","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/s41380-022-01437-6","volume":"27","author":"A Neumann","year":"2022","unstructured":"Neumann A, K\u00fc\u00e7\u00fckali F, Bos I, et al. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with AD CSF profile of neuronal injury and inflammation. Mol Psychiatry. 2022;27(4):1990\u20139.","journal-title":"Mol Psychiatry"},{"issue":"95","key":"1368_CR69","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbi.2021.03.015","volume":"1","author":"LE Oberlin","year":"2021","unstructured":"Oberlin LE, Erickson KI, Mackey R, et al. Peripheral inflammatory biomarkers predict the deposition and progression of amyloid-\u03b2 in cognitively unimpaired older adults. Brain Behav Immun. 2021;1(95):178\u201389.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1368_CR70","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41398-019-0521-7","volume":"9","author":"L Carboni","year":"2019","unstructured":"Carboni L, McCarthy DJ, Delafont B, et al. Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies. Transl Psychiatry. 2019;9(1):182.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1368_CR71","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cao C, Qin XY, et al. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep. 2017;7(1):9094.","journal-title":"Sci Rep"},{"issue":"1","key":"1368_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-023-02843-5","volume":"20","author":"T Liu","year":"2023","unstructured":"Liu T, Zuo H, Ma D, Song D, Zhao Y, Cheng O. Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and AD-associated biomarkers alterations among de novo Parkinson\u2019s disease patients: a prospective cohort study. J Neuroinflammation. 2023;20(1):167.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"1368_CR73","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1212\/WNL.0000000000006082","volume":"91","author":"S Janelidze","year":"2018","unstructured":"Janelidze S, Mattsson N, Stomrud E, et al. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease. Neurology. 2018;91(9):e867\u201377.","journal-title":"Neurology"},{"issue":"8","key":"1368_CR74","doi-asserted-by":"publisher","first-page":"465","DOI":"10.31989\/ffhd.v12i8.954","volume":"12","author":"R Rastmanesh","year":"2022","unstructured":"Rastmanesh R, Solimene U, Lorenzetti A, et al. A randomized, controlled trial on the effectiveness of a proprietary marine lipo-peptide formula vs omega-3 on cytokines profile, anxiety, and pain symptoms in patients with fibromyalgia. Funct Foods Health Dis. 2022;12(8):465\u201378.","journal-title":"Funct Foods Health Dis"},{"key":"1368_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2023.100067","volume":"7","author":"MB Aguiar","year":"2023","unstructured":"Aguiar MB, Barros GH, Colleoni GW, Cendoroglo MS, de Mello AC. Association between C-reactive protein, neutrophils, lymphocytes, cognition, and functional capacity in an oldest old population. Biomarkers Neuropsychiatry. 2023;7:100067.","journal-title":"Biomarkers Neuropsychiatry"},{"issue":"208","key":"1368_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112064","volume":"1","author":"V Moisoiu","year":"2021","unstructured":"Moisoiu V, Iancu SD, Stefancu A, et al. SERS liquid biopsy: an emerging tool for medical diagnosis. Colloids Surf, B. 2021;1(208):112064.","journal-title":"Colloids Surf, B"},{"issue":"2","key":"1368_CR77","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/cyt.12661","volume":"30","author":"RK Ghosh","year":"2019","unstructured":"Ghosh RK, Pandey T, Dey P. Liquid biopsy: a new avenue in pathology. Cytopathology. 2019;30(2):138\u201343.","journal-title":"Cytopathology"},{"issue":"9","key":"1368_CR78","first-page":"1501","volume":"45","author":"P Reinartz","year":"2004","unstructured":"Reinartz P, Wildberger JE, Schaefer W, Nowak B, Mahnken AH, Buell U. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V\/Q lung scintigraphy in SPECT technique and multislice spiral CT. J Nucl Med. 2004;45(9):1501\u20138.","journal-title":"J Nucl Med"},{"issue":"52","key":"1368_CR79","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10462-018-09679-z","volume":"1","author":"G Nguyen","year":"2019","unstructured":"Nguyen G, Dlugolinsky S, Bob\u00e1k M, et al. Machine learning and deep learning frameworks and libraries for large-scale data mining: a survey. Artif Intell Rev. 2019;1(52):77\u2013124.","journal-title":"Artif Intell Rev"},{"issue":"5-6","key":"1368_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201900408","volume":"20","author":"KS Kudryashova","year":"2020","unstructured":"Kudryashova KS, Burka K, Kulaga AY, Vorobyeva NS, Kennedy BK. Aging biomarkers: from functional tests to multi\u2010omics approaches. Proteomics. 2020;20(5\u20136):1900408.","journal-title":"Proteomics"},{"issue":"1","key":"1368_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12050","volume":"6","author":"J Cummings","year":"2020","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. AD drug development pipeline: 2020. Alzheimers Dement N Y Transl Res Clin Interv. 2020;6(1):e12050.","journal-title":"Alzheimers Dement N Y Transl Res Clin Interv"},{"issue":"12","key":"1368_CR82","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911170","volume":"11","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Insel PS, Stomrud E, et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in AD. EMBO Mol Med. 2019;11(12):e11170.","journal-title":"EMBO Mol Med"},{"issue":"12","key":"1368_CR83","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.7150\/thno.72258","volume":"12","author":"P Parekh","year":"2022","unstructured":"Parekh P, Mu Q, Badachhape A, Bhavane R, et al. A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022;12(12):5504.","journal-title":"Theranostics"},{"issue":"10","key":"1368_CR84","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/metabo12100949","volume":"12","author":"M Fran\u00e7ois","year":"2022","unstructured":"Fran\u00e7ois M, Karpe AV, Liu JW, et al. Multi-omics, an integrated approach to identify novel blood biomarkers of AD. Metabolites. 2022;12(10):949.","journal-title":"Metabolites"},{"issue":"3","key":"1368_CR85","doi-asserted-by":"publisher","first-page":"ooab052","DOI":"10.1093\/jamiaopen\/ooab052","volume":"4","author":"S Kumar","year":"2021","unstructured":"Kumar S, Oh I, Schindler S, Lai AM, Payne PR, Gupta A. Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review. JAMIA Open. 2021;4(3):ooab052.","journal-title":"JAMIA Open."},{"issue":"11","key":"1368_CR86","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3390\/genes12111753","volume":"12","author":"H Tang","year":"2021","unstructured":"Tang H, Harte M. Investigating markers of the NLRP3 inflammasome pathway in AD: a human post-mortem study. Genes. 2021;12(11):1753.","journal-title":"Genes"},{"issue":"226","key":"1368_CR87","doi-asserted-by":"publisher","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","volume":"6","author":"AM Fagan","year":"2014","unstructured":"Fagan AM, Xiong C, Jasielec MS, et al. Longitudinal change in CSF biomarkers in autosomal-dominant AD. Sci Transl Med. 2014;6(226):226ra30.","journal-title":"Sci Transl Med."},{"issue":"2","key":"1368_CR88","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/brain\/awac128","volume":"146","author":"J Stevenson-Hoare","year":"2023","unstructured":"Stevenson-Hoare J, Heslegrave A, Leonenko G, et al. Plasma biomarkers and genetics in the diagnosis and prediction of AD. Brain. 2023;146(2):690\u20139.","journal-title":"Brain"},{"issue":"3","key":"1368_CR89","first-page":"1119","volume":"60","author":"BL Reijs","year":"2017","unstructured":"Reijs BL, Ramakers IH, K\u00f6hler S, et al. Memory correlates of AD cerebrospinal fluid markers: a longitudinal cohort study. Journal of AD. 2017;60(3):1119\u201328.","journal-title":"Journal of AD"},{"issue":"1","key":"1368_CR90","volume":"13","author":"A Shiino","year":"2021","unstructured":"Shiino A, Shirakashi Y, Ishida M, Tanigaki K, Japanese AD Neuroimaging Initiative. Machine learning of brain structural biomarkers for AD (AD) diagnosis, prediction of disease progression, and amyloid beta deposition in the Japanese population. Alzheimer\u2019s Dementia Diagn Assess Dis Monit. 2021;13(1):e12246.","journal-title":"Alzheimer's Dementia Diagn Assess Dis Monit"},{"key":"1368_CR91","doi-asserted-by":"crossref","unstructured":"Tosun D, Yardibi O, Benzinger TL, et al. Identifying individuals with non\u2010AD co\u2010pathologies: a precision medicine approach to clinical trials in sporadic AD. Alzheimer\u2019s Dementia. 2023.","DOI":"10.1002\/alz.13447"},{"issue":"9","key":"1368_CR92","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.molmed.2022.05.008","volume":"28","author":"J Therriault","year":"2022","unstructured":"Therriault J, Zimmer ER, Benedet AL, Pascoal TA, Gauthier S, Rosa-Neto P. Staging of AD: past, present, and future perspectives. Trends Mol Med. 2022;28(9):726\u201341.","journal-title":"Trends Mol Med"},{"issue":"10","key":"1368_CR93","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","volume":"88","author":"KS Lai","year":"2017","unstructured":"Lai KS, Liu CS, Rau A, et al. Peripheral inflammatory markers in AD: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry. 2017;88(10):876\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1368_CR94","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jalz.2016.11.007","volume":"13","author":"MW Weiner","year":"2017","unstructured":"Weiner MW, Veitch DP, Aisen PS, et al. Recent publications from the AD neuroimaging initiative: reviewing progress toward improved AD clinical trials. Alzheimers Dement. 2017;13(4):e1-85.","journal-title":"Alzheimers Dement"},{"key":"1368_CR95","doi-asserted-by":"crossref","unstructured":"Meraz-R\u00edos, Marco Antonio, Lory JheniferRoch\u00edn-Hern\u00e1ndez, et al. \u201cThe Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial AD Reveals New Insights for AD Study.\u201d (2023).","DOI":"10.20944\/preprints202307.0854.v1"},{"issue":"1","key":"1368_CR96","first-page":"1","volume":"5","author":"S Wang","year":"2017","unstructured":"Wang S, Liu Z, Ye T, et al. Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers. Actaneuropathol commun. 2017;5(1):1\u20133.","journal-title":"Actaneuropathol commun"},{"issue":"4","key":"1368_CR97","first-page":"1667","volume":"85","author":"M Dhaynaut","year":"2022","unstructured":"Dhaynaut M, Sprugnoli G, Cappon D, et al. Impact of 40 Hz transcranial alternating current stimulation on cerebral tau burden in patients with AD: a case series. Journal of AD. 2022;85(4):1667\u201376.","journal-title":"Journal of AD"},{"issue":"4","key":"1368_CR98","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/15622975.2017.1375556","volume":"19","author":"P Lewczuk","year":"2018","unstructured":"Lewczuk P, Riederer P, O\u2019bryant SE, et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the consensus of the task force on biological markers in psychiatry of the world federation of societies of biological psychiatry. World J Biol Psychiatry. 2018;19(4):244\u2013328.","journal-title":"World J Biol Psychiatry."},{"key":"1368_CR99","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s40520-016-0535-4","volume":"28","author":"A Breining","year":"2016","unstructured":"Breining A, Silvestre JS, Dieudonn\u00e9 B, et al. Biomarkers of vascular dysfunction and cognitive decline in patients with AD: no evidence for association in elderly subjects. Aging Clin Exp Res. 2016;28:1133\u201341.","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"1368_CR100","first-page":"1359","volume":"59","author":"E Lawrence","year":"2017","unstructured":"Lawrence E, Vegvari C, Ower A, Hadjichrysanthou C, De Wolf F, Anderson RM. A systematic review of longitudinal studies which measure AD biomarkers. Journal of AD. 2017;59(4):1359\u201379.","journal-title":"Journal of AD"},{"issue":"3","key":"1368_CR101","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/jpm10030138","volume":"10","author":"WJ Lukiw","year":"2020","unstructured":"Lukiw WJ, Vergallo A, Lista S, Hampel H, Zhao Y. Biomarkers for AD (AD) and the application of precision medicine. J Personal Med. 2020;10(3):138.","journal-title":"J Personal Med"},{"issue":"1","key":"1368_CR102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/wound.2020.1175","volume":"10","author":"J Laloze","year":"2021","unstructured":"Laloze J, Fi\u00e9vet L, Desmouli\u00e8re A. Adipose-derived mesenchymal stromal cells in regenerative medicine: state of play, current clinical trials, and future prospects. Adv Wound Care. 2021;10(1):24\u201348.","journal-title":"Adv Wound Care"},{"issue":"11","key":"1368_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141649","volume":"10","author":"T Karlas","year":"2015","unstructured":"Karlas T, Dietrich A, Peter V, et al. Evaluation of transient elastography, acoustic radiation force impulse imaging (ARFI), and enhanced liver function (ELF) score for detection of fibrosis in morbidly obese patients. PLoS ONE. 2015;10(11):e0141649.","journal-title":"PLoS ONE"},{"issue":"1","key":"1368_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-022-00296-z","volume":"11","author":"TO Klyucherev","year":"2022","unstructured":"Klyucherev TO, Olszewski P, Shalimova AA, et al. Advances in the development of new biomarkers for AD. Transl Neurodegener. 2022;11(1):1\u201324.","journal-title":"Transl Neurodegener"},{"issue":"6","key":"1368_CR105","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2003.14.6.11","volume":"17","author":"A Qui\u00f1ones-Hinojosa","year":"2004","unstructured":"Qui\u00f1ones-Hinojosa A, Jun P, Jacobs R, Rosenberg WS, Weinstein PR. General principles in the medical and surgical management of spinal infections: a multidisciplinary approach. Neurosurg focus. 2004;17(6):E1.","journal-title":"Neurosurg focus"},{"issue":"03","key":"1368_CR106","first-page":"401","volume":"7","author":"M Azeem","year":"2022","unstructured":"Azeem M, Haleem A, Javaid M. Symbiotic relationship between machine learning and Industry 4.0: a review. J Ind Integr Manag. 2022;7(03):401\u201333.","journal-title":"J Ind Integr Manag."},{"key":"1368_CR107","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13139-016-0393-1","volume":"50","author":"JH Jung","year":"2016","unstructured":"Jung JH, Choi Y, Im KC. PET\/MRI: technical challenges and recent advances. Nucl Med Mol Imaging. 2016;50:3\u201312.","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"1368_CR108","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/bios12020073","volume":"12","author":"JO Olmedo-Aguirre","year":"2022","unstructured":"Olmedo-Aguirre JO, Reyes-Campos J, Alor-Hern\u00e1ndez G, Machorro-Cano I, Rodr\u00edguez-Mazahua L, S\u00e1nchez-Cervantes JL. Remote healthcare for elderly people using wearables: a review. Biosensors. 2022;12(2):73.","journal-title":"Biosensors"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01368-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:02:15Z","timestamp":1775145735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01368-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":108,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01368-2","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"57"}}